Chimeric Antigen Receptor T-Cell (CAR-T) Cells in Patients With R/R T-LBL

Clinical trial NCT05554575 · UNKNOWN

Trial details

NCT number: NCT05554575
Sponsor: Bioceltech Therapeutics, Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

T Cell Lymphoblastic Lymphoma

Start date: 2022-10-01
Primary completion: 2024-09-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.